In clinical advancement, strategies with more realistic value include local delivery or use as adjuvant therapy, rather than relying on long-term systemic exposure
For example, some studies on oral semaglutide showed an increase in thyroxine exposure, likely because the medication sat in the stomach longer, allowing for more absorption time
It's one of the most common questions we get, and honestly, its one of the most important
This recent original paper presents data on a potential new treatment for WD, which may address some unmet needs associated with currently available therapies
These are no longer limited to medications for diabetes or weight loss
We answer all six the same way, on every patient, every time